Syringe
Latest GALDERMA HOLDING SA Patents:
The broken lines in the drawings illustrate portions of the syringe and form no part of the claimed design. The break lines indicate that the appearance of any portion of the syringe between the break lines forms no part of the claimed design.
Claims
We claim the ornamental design for a syringe, as shown and described.
D397790 | September 1, 1998 | Naganuma |
D425198 | May 16, 2000 | Porta |
D620591 | July 27, 2010 | Young |
D641078 | July 5, 2011 | Morgan |
D668760 | October 9, 2012 | Kawamura |
D675317 | January 29, 2013 | Baxter et al. |
D710005 | July 29, 2014 | Kawamura |
D777325 | January 24, 2017 | Aneas |
D790691 | June 27, 2017 | Davis et al. |
D793552 | August 1, 2017 | Schiller et al. |
D794185 | August 8, 2017 | Dolk et al. |
D796670 | September 5, 2017 | Dolk |
D797282 | September 12, 2017 | Dolk et al. |
D798444 | September 26, 2017 | Darras et al. |
D799034 | October 3, 2017 | Nguyen |
D800900 | October 24, 2017 | Darras et al. |
D812223 | March 6, 2018 | Evans et al. |
D814026 | March 27, 2018 | Darras et al. |
D815279 | April 10, 2018 | Darras et al. |
D842463 | March 5, 2019 | Grunhut |
D845476 | April 9, 2019 | Evans et al. |
D865949 | November 5, 2019 | Mandaroux |
D866753 | November 12, 2019 | Mandaroux |
D867582 | November 19, 2019 | Mandaroux |
10857306 | December 8, 2020 | Holmqvist |
D914208 | March 23, 2021 | Shabudin et al. |
D954942 | June 14, 2022 | Lee |
20090137966 | May 28, 2009 | Rueckert et al. |
20120220948 | August 30, 2012 | Barbour |
20180243513 | August 30, 2018 | Rolfs et al. |
008584866-0001 | June 2021 | EM |
1802332-0002 | July 2019 | HK |
D1067331 | April 2000 | JP |
300926536 | October 2017 | KR |
300926537 | October 2017 | KR |
300932430.0000 | November 2017 | KR |
101900427 | September 2018 | KR |
301158293 | April 2022 | KR |
WO-2017/176476 | October 2017 | WO |
WO-2021/220228 | November 2021 | WO |
- Restylane Defyne (1X1ML) QMED Galderma, Restylane—QMED—Galderma, France HEalth, [Post date unknown], site seen [Jul. 20, 2022], Seen at URL: https://www.france-health.com/en/home/4894-restylane-defyne-1x1ml-qmed-galderma.html (Year: 2022).
- Author: Thierry, Bi-Soft, Reinventing the syringe, Anti-age Magazine, [Post date: Unknown], [Site seen Jul. 20, 2022], Seen at URL: https://en.anti-age-magazine.com/bi-soft-re-inventing-syringe/ (Year: 2022).
- International Search Report and Written Opinion for related International Patent Application No. PCT/IB2021/053601 dated May 25, 2021.
- U.S. Appl. No. 29/763,036, filed Dec. 21, 2020, Galderma S.A.
- Excerpt from “BD add-on finger flange,” BD, bd.com, 2022, 1 page, https://drugdeliverysystems.bd.com/products/safety-and-shielding-systems/add-on-finger-flange (accessed Jul. 14, 2022).
- “Restylane Defyne (1×1 ML) QMED Galderma,” Restylane—QMED—Galderma, France-Health, https://www.france-health.com/en/home/4894-restylane-defyne-1x1ml-qmed-galderma.html, (accessed Jul. 14, 2022), 1 page.
- Notice of Allowance on U.S. Appl. No. 29/763,036 dated Aug. 8, 2022 (8 pages).
Type: Grant
Filed: Jun 21, 2021
Date of Patent: Dec 27, 2022
Assignee: GALDERMA HOLDING SA (Zug)
Inventors: Oliver Tyrsing (Uppsala), Oscar Ullsten (Uppsala)
Primary Examiner: Natasha Vujcic
Assistant Examiner: Gilbert B Ford
Application Number: 29/795,863